Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sickle Cell Disease Association of America
7240 Parkway Drive, Suite 180Hanover, Maryland, United States
Email Phone Web
The vision for a national coordinated approach to addressing issues related to sickle cell disease was unveiled in 1971 when representatives of 15 community sickle cell organizations met at “Wingspread,” a Racine, Wisconsin conference center, as guest of the Johnson Foundation. Out of that meeting, the National Association for Sickle Cell Disease was created. The name was changed to Sickle Cell Disease Association of America, Inc. in 1994.
Our mission: “To advocate for and enhance our membership’s ability to improve the quality of health, life and services for individuals, families and communities affected by sickle cell disease and related conditions, while promoting the search for a cure for all people in the world with sickle cell disease. The Strategies defined at the “Wingspread” meeting laid the foundation for today’s Association.
-Provide leadership on a national level to create awareness of the negative impact of sickle cell disease on the health, economic, social and educational well-being of the individual and his or her family.
-Prepare and distribute substantive educational materials.
Related Content
-
Let Your Light Shine: Sickle SocialPiedmont Health Services and Sickle Cell...
-
23andMe, Morehouse School of Medicine and the Sickle Cell Foundation of Georgia Inc. launches the Sickle Cell Carrie...Atlanta, GA: April 11, 2023 — 23andMe ...
-
William Owen, MDDr. William Owen is a pediatric hematolo...
-
Iris Buchanan-Perry, MD, MSc, FAAPDr. Buchanan serves as a Clinical Instru...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
The Sickle Cell Care Coordination InitiativeThe Sickle Cell Care Coordination Initia...
-
Phase 3 study of L-Glutamine in sickle cell disease: Analyses of time to first and second crisis and average cumulat...A Phase 3, double-blind, randomized, pla...